These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35205091)

  • 1. Platelet-Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases.
    Pluta K; Porębska K; Urbanowicz T; Gąsecka A; Olasińska-Wiśniewska A; Targoński R; Krasińska A; Filipiak KJ; Jemielity M; Krasiński Z
    Biology (Basel); 2022 Jan; 11(2):. PubMed ID: 35205091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Platelet-leukocyte Aggregates Are Associated With Myocardial No-reflow in Patients With ST Elevation Myocardial Infarction.
    Ren F; Mu N; Zhang X; Tan J; Li L; Zhang C; Dong M
    Am J Med Sci; 2016 Sep; 352(3):261-6. PubMed ID: 27650230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates.
    Li N; Goodall AH; Hjemdahl P
    Br J Haematol; 1997 Dec; 99(4):808-16. PubMed ID: 9432026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?
    Klinkhardt U; Harder S
    Semin Thromb Hemost; 2005; 31(4):400-3. PubMed ID: 16149016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates.
    Brambilla M; Camera M; Colnago D; Marenzi G; De Metrio M; Giesen PL; Balduini A; Veglia F; Gertow K; Biglioli P; Tremoli E
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):947-53. PubMed ID: 18292391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction.
    Michelson AD; Barnard MR; Krueger LA; Valeri CR; Furman MI
    Circulation; 2001 Sep; 104(13):1533-7. PubMed ID: 11571248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure.
    Gawaz M; Fateh-Moghadam S; Pilz G; Gurland HJ; Werdan K
    Eur J Clin Invest; 1995 Nov; 25(11):843-51. PubMed ID: 8582450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.
    Sibbing D; Aradi D; Jacobshagen C; Gross L; Trenk D; Geisler T; Orban M; Gori T; Hadamitzky M; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Thalmeier A; Löw A; Holdt L; Teupser D; Ince H; Felix SB; Parma R; Malek L; Horstkotte J; Baylacher M; Schwinger R; Rieber J; Mudra H; Hausleiter J; Huber K; Neumann FJ; Koltowski L; Huczek Z; Mehilli J; Massberg S;
    Thromb Haemost; 2017 Jan; 117(1):188-195. PubMed ID: 27652610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activation of platelet-neutrophil mediated by platelet-activating factor].
    Guo NJ; Chang YL; Xiao DJ; Huang P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):447-51. PubMed ID: 15972139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary Artery Bypass Grafting or Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease.
    Di Gioia G; Soto Flores N; Franco D; Colaiori I; Sonck J; Gigante C; Kodeboina M; Bartunek J; Vanderheyden M; Van Praet F; Casselman F; Degriek I; Stockman B; Barbato E; Collet C; De Bruyne B
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009157. PubMed ID: 33040579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
    Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
    Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet Therapy in Acute Coronary Syndromes. Lights and Shadows of Platelet Function Tests to Guide the Best Therapeutic Approach.
    Cimmino G; Gallinoro E; Di Serafino L; De Luca N; Cirillo P
    Curr Vasc Pharmacol; 2020; 18(3):262-272. PubMed ID: 31092181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tissue factor expression of platelets and leukocytes in patients with acute coronary syndromes].
    Lu HY; Chen D; Gu J; Song LX; Chen M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):678-83. PubMed ID: 23815921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
    Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
    Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease.
    Jia S; Zhang C; Jiang L; Xu L; Tian J; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Yuan J; Song L
    Circ J; 2020 Sep; 84(10):1718-1727. PubMed ID: 32848116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Luo Y; Li J; Liu X; Xu J; Ye Z; Yao Y; Liu X; Lai Y
    Thromb Res; 2016 Mar; 139():114-20. PubMed ID: 26916306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis.
    Irving PM; Macey MG; Feakins RM; Knowles CH; Frye JN; Liyanage SH; Dorudi S; Williams NS; Rampton DS
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):283-9. PubMed ID: 18334871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Role of Platelet Function Testing in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.
    Gross L; Sibbing D
    Interv Cardiol Clin; 2017 Jan; 6(1):151-166. PubMed ID: 27886819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by Abciximab.
    Ray MJ; Walters DL; Bett JN; Cameron J; Wood P; Aroney CN
    Int J Cardiol; 2005 May; 101(2):249-55. PubMed ID: 15882672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.